The aim of this study was to evaluate the feasibility of transjugular intrahepatic portosystemic shunts using FLUENCY expanded polytetraf luoroethylene (PTFE)-covered stents and the effect on the patency rate. A total of 114 cirrhotic patients who were treated by transjugular intrahepatic portosystemic stent shunt (TIPS) placement using a FLUENCY expanded, PTFE-covered stent were enrolled in th...

MACEs in the early-surgery group occurred in patients in whom antiplatelet therapy was discontinued, including 3 events in the 17 patients with bare-metal stents in whom antiplatelet therapy was discontinued and 2 events in 9 patients with drug-eluting stents without antiplatelet therapy. In contrast to our findings, Reddy et al. (5) did not show an association between discontinuation of antipl...

Transcatheter treatments for coarctation of the aorta include balloon angioplasty and stent implantation. However, balloon angioplasty has its limitations and may be associated with complications, such as, recoarctation, dissection, and aneurysm formation, in adult patients. Bare metal stent implantation has offered an alternative during the last decade or so, but covered stents have been used ...

B y the late 1990s intracoronary brachytherapy had become the gold standard therapy for the treatment of in-stent restenosis (ISR) in bare metal stents. Despite this, the ‘‘uptake’’ of this treatment by the interventional community worldwide, and certainly in the UK, was low. In 2005, drug eluting stents (DES) have entered the interventional armamentarium. The potential for DES to lower the pri...

OBJECTIVE At 4-year follow-up, paclitaxel-eluting stents (PES, TAXUS) have demonstrated clinical effectiveness in reducing restenosis without increasing death or myocardial infarction. Concerns remain with all drug-eluting stents, however, regarding potential interference with long-term healing, particularly in zones with adjacent stent overlap due to theoretical doubling in both drug release a...

OBJECTIVES The purpose of this research was to determine the relative safety and efficacy of multiple (> or =2) overlapping Cypher sirolimus-eluting stents (SES) (Johnson & Johnson, New Brunswick, New Jersey). BACKGROUND Overlapping coronary stents are common. The periprocedural and late clinical and angiographic consequences of overlapped coronary stents are not clearly defined, particularly...

n this issue of the Journal, Togni et al. (1) report that xercise-induced coronary vasomotion is abnormal in segents proximal and distal to sirolimus-eluting stents (SES) hen evaluated six months after deployment. While subects who had received bare-metal stents demonstrated ormal exercise-induced vasodilation, subjects with SES learly demonstrated paradoxical vasoconstriction in peritent segme...